SNRIs (serotonin norepinephrine reuptake inhibitors) are relatively recent antidepressants. SNRIs include:
- Duloxetine (Cymbalta®)
- Desvenlafaxine (Pristiq®)
- Levomilnacipran (Fetzima™)
- Venlafaxine (Effexor®, Effexor XR®).
Aplenzin® is a new antidepressant that is a long-acting, once-a-day form of bupropion (Budeprion XL®, Budeprion SR®, Buproban®, Wellbutrin SR®, Wellbutrin XL®, Wellbutrin®, Zyban®), a norepinephrine and dopamine reuptake inhibitor.
For many people, new antidepressants offer the hope of an effective and well-tolerated depression treatment. However, for many people, a new antidepressant is nothing more than a costly medication (when a less costly alternative would work just fine). Only you and your healthcare provider can decide whether you should try an antidepressant that is new.